4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lung Function Decline after 24 Weeks of Moxa Smoke Exposure in Rats

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Moxibustion is a complementary therapy that has been used for thousands of years. Burning moxa produces smoke and inhalable particulates. Recent research has indicated that smoke inhalation is associated with negative lung effects. This study aimed to evaluate the lung function of rats after moxa smoke exposure at different concentrations.

          Methods

          Using a randomised block experiment design, 28 male Wistar rats were randomly divided into three moxa smoke groups (opacity) (n=7): low concentration (27.45 mg/m 3), medium concentration (168.76 mg/m 3), and high concentration (384.67 mg/m 3) with a control group. Rats in the moxa smoke groups were exposed in an automatic dynamic exposure device separately with different concentrations for 20 min/d, 6d/week, for 24 weeks. Rats in the control group were exposed in the same space without moxa smoke. Lung function was evaluated by the AniRes 2005 animal pulmonary function analysing system. Statistical Product and Service Solutions 18.0 software was used for data analysis.

          Results

          In the study, no deaths were found in any group. There was no difference of forced expiratory volume in one second/forced vital capacity percentage (FEV1/FVC%), inspiratory resistance (Ri), and expiratory resistance (Re) among each group after 24 weeks of moxa smoke exposure (P>0.05). Compared with the control group (0.33 ml/cmH 20), dynamic compliance (Cdyn) was reduced in the medium (0.29 ml/cmH 20) and high (0.25 ml/cmH 20) concentration groups (P<0.05); however, Cdyn in the low concentration group (0.29 ml/cmH 20) was not significantly affected.

          Conclusion

          Moxa smoke exposure at low concentrations did not affect the rat's lung function. Moxa smoke of medium and high concentrations destroyed the lung function represented by decreased Cdyn. However, moxa smoke of low concentrations (27.45 mg/m 3) is much higher than the concentration in a regular moxibustion clinic (3.54 mg/m 3). Moxa smoke at higher concentrations might destroy the lung function. The safety evaluation of moxa smoke requires further research.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          Ambient odor of orange in a dental office reduces anxiety and improves mood in female patients

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.

            In chronic obstructive pulmonary disease (COPD) patients, small-airway dysfunction (SAD) is considered a functional hallmark of disease. However, the exact role of SAD in the clinical presentation of COPD is not yet completely understood; moreover, it is not known whether SAD may have a relationship with the impact of disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Pulmonary vascular dysfunction in ARDS

              Acute respiratory distress syndrome (ARDS) is characterised by diffuse alveolar damage and is frequently complicated by pulmonary hypertension (PH). Multiple factors may contribute to the development of PH in this setting. In this review, we report the results of a systematic search of the available peer-reviewed literature for papers that measured indices of pulmonary haemodynamics in patients with ARDS and reported on mortality in the period 1977 to 2010. There were marked differences between studies, with some reporting strong associations between elevated pulmonary arterial pressure or elevated pulmonary vascular resistance and mortality, whereas others found no such association. In order to discuss the potential reasons for these discrepancies, we review the physiological concepts underlying the measurement of pulmonary haemodynamics and highlight key differences between the concepts of resistance in the pulmonary and systemic circulations. We consider the factors that influence pulmonary arterial pressure, both in normal lungs and in the presence of ARDS, including the important effects of mechanical ventilation. Pulmonary arterial pressure, pulmonary vascular resistance and transpulmonary gradient (TPG) depend not alone on the intrinsic properties of the pulmonary vascular bed but are also strongly influenced by cardiac output, airway pressures and lung volumes. The great variability in management strategies within and between studies means that no unified analysis of these papers was possible. Uniquely, Bull et al. (Am J Respir Crit Care Med 182:1123–1128, 2010) have recently reported that elevated pulmonary vascular resistance (PVR) and TPG were independently associated with increased mortality in ARDS, in a large trial with protocol-defined management strategies and using lung-protective ventilation. We then considered the existing literature to determine whether the relationship between PVR/TPG and outcome might be causal. Although we could identify potential mechanisms for such a link, the existing evidence does not allow firm conclusions to be drawn. Nonetheless, abnormally elevated PVR/TPG may provide a useful index of disease severity and progression. Further studies are required to understand the role and importance of pulmonary vascular dysfunction in ARDS in the era of lung-protective ventilation.
                Bookmark

                Author and article information

                Contributors
                Journal
                Evid Based Complement Alternat Med
                Evid Based Complement Alternat Med
                ECAM
                Evidence-based Complementary and Alternative Medicine : eCAM
                Hindawi
                1741-427X
                1741-4288
                2019
                10 January 2019
                10 January 2019
                : 2019
                : 9236742
                Affiliations
                1Beijing University of Chinese Medicine, Beijing, China
                2Beijing Electric Power Hospital, Beijing, China
                3Beijing Hospital of Acupuncture and Moxibustion, Beijing, China
                4Chongqing Yubei District Hospital of Traditional Chinese Medicine, Chongqing, China
                5China Academy of Chinese Medical Sciences, Beijing, China
                Author notes

                Academic Editor: Jian Kong

                Author information
                http://orcid.org/0000-0001-5639-107X
                http://orcid.org/0000-0003-3436-2811
                http://orcid.org/0000-0002-0618-3181
                http://orcid.org/0000-0003-3644-6883
                Article
                10.1155/2019/9236742
                6348917
                30755777
                299027ef-d5c6-4e36-a358-97fd7d434536
                Copyright © 2019 Rui He et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 August 2018
                : 3 December 2018
                : 20 December 2018
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 81403449
                Award ID: 81343070
                Funded by: National Key Basic Research and Development
                Award ID: 2009CB522906
                Categories
                Research Article

                Complementary & Alternative medicine
                Complementary & Alternative medicine

                Comments

                Comment on this article